股本结构
单位:万股
公告日期 | 2024-03-06 | 2024-01-23 | 2024-01-23 | 2023-11-09 | 2023-11-09 | 2023-08-09 |
---|---|---|---|---|---|---|
证券总股本 | 2337.04 | 2330.00 | 28010.00 | 27298.64 | 26973.15 | 26807.49 |
普通股本 | 2337.04 | 2330.00 | 28010.00 | 27298.64 | 26973.15 | 26807.49 |
优先股 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
变动日期 | 2024-03-01 | 2024-01-25 | 2024-01-23 | 2023-11-08 | 2023-09-30 | 2023-08-07 |
注释:中概股证券总股本=普通股股本/
存托凭证比例
历史变动
公告日期 | 变动后普通股本(万股) | 变动后优先股(万股) | 变动原因 | 变动日期 |
---|---|---|---|---|
2024-03-06 | 2337.04 | 未披露 | 定期报告 | 2024-03-01 |
2024-01-23 | 2330.00 | 未披露 |
更多>>
INOVIO announced that a 1-for-12 reverse stock split of its outstanding shares of common stock will be effective as of 5:00 p.m. Eastern Time on Wednesday, January 24, 2024.
|
2024-01-25 |
2024-01-23 | 28010.00 | 未披露 | 定期报告 | 2024-01-23 |
2023-11-09 | 27298.64 | 未披露 | 定期报告 | 2023-11-08 |
2023-11-09 | 26973.15 | 未披露 |
更多>>
From June 30, 2023 to September 30, 2023
Issuance of common stock for cash, net of financing costs
Vesting of RSUs, net of tax payments
|
2023-09-30 |
2023-08-09 | 26807.49 | 未披露 | 定期报告 | 2023-08-07 |
2023-05-10 | 26274.01 | 未披露 | 定期报告 | 2023-05-08 |
2023-05-10 | 26273.91 | 0.0009 |
更多>>
From December 31, 2022 to March 31, 2023
Issuance of common stock for legal settlement
Vesting of RSUs, net of tax payments
|
2023-03-31 |
2023-03-28 | 26273.91 | 未披露 | 定期报告 | 2023-03-17 |
2023-03-01 | 26013.20 | 未披露 | 定期报告 | 2023-02-24 |
2023-03-01 | 25309.13 | 0.0009 |
更多>>
From December 31, 2021 to December 31, 2022
Exercise of stock options for cash and vesting of RSUs, net of tax payments
Issuance of common stock for cash, net of financing costs
|
2022-12-31 |
2022-11-08 | 24948.93 | 未披露 | 定期报告 | 2022-11-07 |
2022-11-08 | 24948.53 | 0.0009 |
更多>>
From June 30, 2022 to September 30, 2022
Issuance of common stock for cash, net of financing costs
Exercise of stock options for cash and vesting of RSUs, net of tax payments
|
2022-09-30 |
2022-08-09 | 24940.05 | 未披露 | 定期报告 | 2022-08-05 |
2022-08-09 | 24750.45 | 0.0009 |
更多>>
From March 31, 2022 to June 30, 2022
Issuance of common stock for cash, net of financing costs
Exercise of stock options for cash and vesting of RSUs, net of tax payments
|
2022-06-30 |
2022-05-10 | 22904.11 | 未披露 | 定期报告 | 2022-05-09 |
2022-05-10 | 22651.07 | 0.0009 |
更多>>
From December 31, 2021 to March 31, 2022
Issuance of common stock for cash, net of financing costs
Exercise of stock options for cash and vesting of RSUs, net of tax payments
|
2022-03-31 |
2022-03-25 | 22177.85 | 未披露 | 定期报告 | 2022-03-17 |
2022-03-01 | 21740.33 | 未披露 | 定期报告 | 2022-02-25 |
2022-03-01 | 21738.29 | 0.0009 |
更多>>
From December 31, 2020 to December 31, 2021
Issuance of common stock for cash, net of capital raising related expenses
Conversion of December 2019 Bonds to common stock
Exercise of stock options for cash and vesting of RSUs, net of tax payments
|
2021-12-31 |
2021-11-09 | 21038.59 | 未披露 | 定期报告 | 2021-11-05 |
2021-11-09 | 21036.28 | 0.0009 |
更多>>
From June 30, 2021 to September 30, 2021
Exercise of stock options for cash and vesting of RSUs, net of tax payments
|
2021-09-30 |
2021-08-09 | 21035.69 | 未披露 | 定期报告 | 2021-08-06 |
2021-08-09 | 21014.69 | 0.0009 |
更多>>
From March 31, 2021 to June 30, 2021
Exercise of stock options for cash and vesting of RSUs, net of tax payments
|
2021-06-30 |
2021-05-10 | 20939.93 | 未披露 | 定期报告 | 2021-05-06 |
2021-05-10 | 20933.40 | 0.0009 |
更多>>
From December 31, 2020 To March 31, 2021
Issuance of common stock for cash, net of financing costs of $531,000
Conversion of December 2019 Bonds to common stock
Exercise of stock options for cash and vesting of RSUs, net of tax payments
|
2021-03-31 |
2021-03-25 | 20830.60 | 0.0009 | 定期报告 | 2021-03-16 |
2021-03-01 | 20763.26 | 未披露 | 定期报告 | 2021-02-26 |
2021-01-25 | 20409.28 | 未披露 |
更多>>
1.Common stock offered by the company 17,700,000 shares of common stock.
2.The above discussion is based on 186,392,777 shares of common stock outstanding, which represents 167,528,435 shares of common stock outstanding as of September 30, 2020.
|
2021-01-25 |
2021-03-01 | 18685.15 | 0.0009 |
更多>>
from December 31, 2019 to December 31, 2020
Conversion of preferred stock to common stock
Issuance of common stock for cash
Conversion of senior notes to common stock
Conversion of August 2019 Bonds to common stock
Exercise of stock options for cash and vesting of RSUs, net of tax payments
|
2020-12-31 |
2020-11-09 | 16940.90 | 未披露 | 定期报告 | 2020-11-05 |
2020-11-09 | 16752.84 | 未披露 |
更多>>
From June 30, 2020 to September 30, 2020
Conversion of senior notes to common stock
Conversion of August 2019 Bonds to common stock
Exercise of stock options for cash and vesting of RSUs,net of tax payments
|
2020-09-30 |
2020-08-10 | 16752.04 | 未披露 | 定期报告 | 2020-08-07 |
2020-08-10 | 15875.64 | 未披露 |
更多>>
From March 31, 2020 to June 30, 2020
Conversion of preferred stock to common stock
Exercise of stock options for cash and vesting of RSUs, net of tax payments
Issuance of common stock for cash
|
2020-06-30 |
2020-05-11 | 15809.65 | 未披露 | 定期报告 | 2020-05-08 |
2020-05-11 | 14591.51 | 未披露 |
更多>>
From December 31, 2019 to March 31, 2020
Issuance of common stock for cash
Exercise of stock options for cash and vesting of RSUs, net of tax payments
|
2020-03-31 |
2020-03-27 | 14579.01 | 未披露 | 定期报告 | 2020-03-17 |
2020-03-12 | 14580.31 | 未披露 | 定期报告 | 2020-03-11 |
2020-03-09 | 13776.99 | 未披露 | 定期报告 | 2020-02-29 |
2020-03-12 | 10136.10 | 0.0023 |
更多>>
from December 31, 2018 to December 31, 2019
Issuance of common stock for cash
Exercise of stock options for cash and vesting of RSUs, net of tax payments
|
2019-12-31 |
2019-11-12 | 10001.03 | 未披露 | 定期报告 | 2019-11-07 |
2019-11-12 | 9904.62 | 0.0023 |
更多>>
from June 30, 2019 to September 30, 2019
Issuance of common stock for cash
Vesting of RSUs
|
2019-09-30 |
2019-08-08 | 9902.78 | 未披露 | 定期报告 | 2019-08-05 |
2019-08-08 | 9858.44 | 0.0023 |
更多>>
from March 31, 2019 to June 30,2019
Exercise of stock options and warrants for cash and vesting of RSUs, net of tax payments
|
2019-06-30 |
2019-05-09 | 9803.38 | 未披露 | 定期报告 | 2019-05-06 |
2019-05-09 | 9793.40 | 0.0023 |
更多>>
from December 31, 2018 to March 31, 2019
Issuance of common stock for cash
Exercise of stock options and warrants for cash and vesting of RSUs, net of tax payments
|
2019-03-31 |
2019-03-25 | 9793.40 | 未披露 | 定期报告 | 2019-03-25 |
2019-03-25 | 9762.77 | 0.0023 | 定期报告 | 2019-03-11 |
2019-03-12 | 9763.64 | 未披露 | 定期报告 | 2019-03-08 |
2019-03-12 | 9722.58 | 0.0023 |
更多>>
from December 31, 2017 to December 31, 2018
Issuance of common stock for cash
Exercise of stock options and warrants for cash and vesting of RSUs, net of tax payments
|
2018-12-31 |
2018-11-08 | 9534.71 | 未披露 | 定期报告 | 2018-11-02 |
2018-11-08 | 9447.24 | 0.0023 | 定期报告 | 2018-09-30 |
2018-08-07 | 9149.68 | 未披露 | 定期报告 | 2018-08-03 |
2018-08-07 | 9147.44 | 0.0023 | 定期报告 | 2018-06-30 |
2018-05-09 | 9096.21 | 未披露 | 定期报告 | 2018-05-04 |
2018-05-09 | 9070.49 | 0.0023 | 定期报告 | 2018-03-31 |
2018-03-28 | 9070.08 | 0.0023 | 定期报告 | 2018-03-16 |
2018-03-14 | 9040.39 | 未披露 | 定期报告 | 2018-03-08 |
2018-03-14 | 9035.76 | 0.0023 |
更多>>
from December 31, 2016 to December 31, 2017
Issuance of common stock for cash, net of financing costs of $4.9 million
Exercise of stock options for cash and vesting of RSUs, net of tax payments
|
2017-12-31 |
2017-11-08 | 9029.62 | 未披露 | 定期报告 | 2017-11-03 |
2017-11-08 | 9029.49 | 0.0023 | 定期报告 | 2017-09-30 |
2017-08-08 | 9022.72 | 未披露 | 定期报告 | 2017-08-04 |
2017-08-08 | 7763.38 | 0.0023 | 定期报告 | 2017-06-30 |
2017-05-10 | 7462.70 | 0.0023 | 定期报告 | 2017-03-31 |
2017-03-29 | 7432.41 | 0.0023 | 定期报告 | 2017-03-17 |
2017-03-15 | 7410.14 | 未披露 | 定期报告 | 2017-03-08 |
2017-03-15 | 7406.24 | 0.0023 |
更多>>
From December 31, 2015 to December 31, 2016
Issuance of common stock for cash, net of financing costs of $128,000
Issuance of common stock for Bioject acquisition
Exercise of stock options and warrants for cash, net of tax payments
Cashless exercise of stock options and warrants
|
2016-12-31 |
2016-11-09 | 7406.05 | 未披露 | 定期报告 | 2016-11-01 |
2016-11-09 | 7396.67 | 0.0023 | 定期报告 | 2016-09-30 |
2016-08-08 | 7354.83 | 未披露 | 定期报告 | 2016-08-01 |
2016-08-08 | 7348.29 | 0.0023 | 定期报告 | 2016-06-30 |
2016-05-09 | 7309.71 | 未披露 | 定期报告 | 2016-05-02 |
2016-05-09 | 7226.82 | 0.0023 | 定期报告 | 2016-03-31 |
2016-03-25 | 7222.40 | 0.0023 | 定期报告 | 2016-03-18 |
2016-03-14 | 7222.40 | 未披露 | 定期报告 | 2016-03-07 |
2016-03-14 | 7221.80 | 0.0023 |
更多>>
from December 31, 2014 to December 31, 2015
Issuance of common stock for cash, net of financing costs of $4.0 million
Exercise of stock options and warrants for cash
|
2015-12-31 |
2015-11-09 | 7218.32 | 未披露 | 定期报告 | 2015-11-02 |
2015-11-09 | 7218.08 | 0.0023 | 定期报告 | 2015-09-30 |
2015-08-10 | 7211.68 | 未披露 | 定期报告 | 2015-08-03 |
2015-05-22 | 7181.02 | 0.0023 | 定期报告 | 2015-05-20 |
2015-05-11 | 7181.00 | 未披露 | 定期报告 | 2015-05-05 |
2015-03-16 | 6074.11 | 0.0023 |
更多>>
from December 31, 2013 to December 31, 2014
Issuance of shares related to reverse stock split
Issuance of common stock for cash, net of financing costs of $4.0 million
Conversions of preferred stock to common stock
Exercise of stock options and warrants for cash
Cashless exercise of warrants
|
2014-12-31 |
2014-11-10 | 6059.11 | 未披露 | 定期报告 | 2014-11-03 |
2014-11-10 | 6045.79 | 0.0023 | 定期报告 | 2014-09-30 |
2014-08-11 | 6039.90 | 未披露 | 定期报告 | 2014-08-04 |
2014-08-11 | 6031.77 | 0.0023 |
更多>>
On June 5, 2014, we effectuated a 4-for-1 reverse split of the Company's outstanding common stock
|
2014-06-30 |
2014-05-12 | 24062.98 | 未披露 | 定期报告 | 2014-05-02 |
2014-04-07 | 24014.63 | 0.0026 | 定期报告 | 2014-03-24 |
2014-03-17 | 23960.98 | 未披露 | 定期报告 | 2014-03-07 |
2014-01-31 | 21140.50 | 0.0026 | 定期报告 | 2014-01-29 |
2014-03-17 | 21030.48 | 0.0026 |
更多>>
from December 31, 2012 to December 31, 2013
Issuance of common stock and warrants for cash, net of financing costs of $783,000
Issuance of common stock for cash, net of financing costs of $585,000
Exercise of stock options and warrants for cash
Cashless exercise of warrants
|
2013-12-31 |
2013-11-12 | 20837.65 | 未披露 | 定期报告 | 2013-11-04 |
2013-11-12 | 20762.00 | 0.0026 | 定期报告 | 2013-09-30 |
2013-08-09 | 18990.34 | 未披露 | 定期报告 | 2013-08-08 |
2013-08-09 | 18005.86 | 0.0026 | 定期报告 | 2013-06-30 |
2013-03-29 | 17994.09 | 0.0026 | 定期报告 | 2013-03-25 |
2013-03-18 | 17992.12 | 未披露 | 定期报告 | 2013-03-08 |
2013-03-18 | 14431.30 | 0.0026 |
更多>>
from December 31, 2011 to December 31, 2012
Issuance of common stock for cash, net of financing costs of $164,695
|
2012-12-31 |
2012-11-07 | 13936.38 | 未披露 | 定期报告 | 2012-11-02 |
2012-11-07 | 13705.54 | 0.0026 | 定期报告 | 2012-09-30 |
2012-03-15 | 13496.84 | 0.0026 |
更多>>
from December 31, 2010 to December 31, 2011
Issuance of common stock for cash, net of financing costs of $41,838
Issuance of common stock and warrants for cash, net of financing costs of $1.3 million
Issuance of common stock and warrants for cash, net of financing costs of $314,871
Exercise of stock options and warrants for cash
|
2011-12-31 |
2011-11-07 | 12726.87 | 未披露 | 定期报告 | 2011-10-26 |
2011-11-07 | 12725.69 | 0.0026 | 定期报告 | 2011-09-30 |
2011-05-10 | 12725.69 | 未披露 | 定期报告 | 2011-05-03 |
2011-05-10 | 12725.40 | 0.0026 | 定期报告 | 2011-03-31 |
2011-03-16 | 12725.40 | 未披露 | 定期报告 | 2011-02-24 |
2011-03-16 | 10503.82 | 0.0026 |
更多>>
from December 31, 2009 to December 31, 2010
Issuance of common stock for cash, net of financing costs of $71,839
Exercise of stock options for cash
|
2010-12-31 |
2010-11-12 | 10420.84 | 未披露 | 定期报告 | 2010-11-10 |
2010-11-12 | 10346.65 | 0.0026 | 定期报告 | 2010-09-30 |
2010-08-13 | 10288.99 | 0.0026 | 定期报告 | 2010-06-30 |
2010-03-26 | 10276.57 | 未披露 | 定期报告 | 2010-03-04 |
2010-03-26 | 10274.61 | 0.0026 |
更多>>
from December 31,2008 to December 31,2009
Issuance of common stock to VGX Pharmaceutical Shareholders
Issuance of common stock and warrants for cash, net of financing costs of $1.6 million
Exercise of stock options for cash
Cashless exercise of stock options
Conversions of preferred stock to common stock
Conversion of convertible debt to common stock
Stock-based compensation
|
2009-12-31 |
2009-03-31 | 4404.18 | 未披露 | 定期报告 | 2009-03-16 |
2009-03-31 | 4402.31 | 0.0071 |
更多>>
from December 31,2007 to December 31,2008
Exercise of stock options for cash
Conversions of preferred stock to common stock
Issuance of common stock for consulting services
Stock-based compensation
|
2008-12-31 |
2008-03-17 | 4384.47 | 未披露 | 定期报告 | 2008-03-07 |
2008-03-17 | 4381.47 | 11.34 |
更多>>
from December 31,2006 to December 31,2007
Exercise of warrants for cash
Exercise of stock options for cash
Cashless exercise of warrants
Conversions of preferred stock to common stock
Conversions of ordinary shares to common stock
Issuance of common stock for consulting services
Issuance of common stock for cash, net of issuance costs of $110,313
Share-based compensation
|
2007-12-31 |
2007-03-16 | 3817.62 | 未披露 | 定期报告 | 2007-03-08 |
2007-03-16 | 3563.95 | 102.81 |
更多>>
from December 31,2005 to December 31,2006
Conversions of preferred stock to common stock
Exercise of stock options for cash
Issuance of common stock for patents and other assets
Issuance of common stock for cash, net of issuance costs of $1,161,070
Issuance of common stock for consulting service
Share-based compensation
Imputed and declared dividends
|
2006-12-31 |
2006-03-16 | 2969.97 | 未披露 | 定期报告 | 2006-03-09 |
2006-03-16 | 2946.88 | 156.24 |
更多>>
from December 31,2004 to December 31,2005
Exercise of stock options for cash
Exercise of warrants for cash
Cashless exercise of warrants
Issuance of common stock for cash, net of issuance costs of $997,682
Issuance of Series D preferred stock for acquisition of Inovio AS
Conversions of preferred stock to common stock
Imputed and declared dividends
Upon conversion, the Series C Preferred Stock outstanding as of December 31, 2005 would convert into 495,769 shares of our common stock.
Upon conversion, the Series A and B Preferred Stock would convert into a total of 573,808 shares of our common stock.
|
2005-12-31 |
2005-03-15 | 2001.29 | 未披露 | 定期报告 | 2005-03-02 |
2005-03-15 | 1842.04 | 0.14 |
更多>>
from December 31,2003 to December 31,2004
Exercise of stock options for cash
Exercise of warrants for cash
Cashless exercise of warrants
Conversions of preferred stock to common stock
Declared dividends
Issuance of Series C preferred stock for cash, net of issuance costs of$1,170,363
Reversal of declared dividends
Effective September 13, 2004, we implemented a one-for-four reverse split of our common stock.
|
2004-12-31 |
2004-03-30 | 6931.29 | 未披露 | 定期报告 | 2004-03-12 |
2004-03-30 | 6368.17 | 0.08 |
更多>>
from December 31,2002 to December 31,2003
Issuance of preferred stock net of issuance cost of $1,058,864 for cash
Issuance of common stock for corporate finance services
Exercise of stock options for cash
Exercise of warrants for cash
Conversions of preferred stock to common
Declared dividends
|
2003-12-31 |
2003-03-31 | 5042.36 | 未披露 | 定期报告 | 2003-03-14 |
2003-03-31 | 5039.86 | 未披露 |
更多>>
from December 31,2001 to December 31,2002
Exercise of stock options for cash
Exercise of warrants for cash
Issued pursuant to exercise of special warrants (net of issuance costs of $413,833 incurred in 2002)
Issued pursuant to exercise of series A special warrants
Issued pursuant to exercise of special warrants
Common stock issued pursuant to services
In October 2002, these special warrants were converted into 10,225,891 shares of common stock and 3,557,976 common stock purchaser warrants.
|
2002-12-31 |
2002-04-01 | 3486.02 | 未披露 | 定期报告 | 2002-03-20 |
2002-04-01 | 3376.10 | 未披露 |
更多>>
from MARCH 31,2001 to December 31,2001
Exercise of stock options for cash
|
2001-12-31 |
2001-05-18 | 3375.67 | 未披露 |
更多>>
from MARCH 31,2000 to MARCH 31,2001
For cash
Pursuant to private placement
Pursuant to exercise of stock options
Pursuant to exercise of warrants
Issued for corporate finance services
Issued pursuant to exercise of Special Warrants
Issued pursuant to license agreement
|
2001-03-31 |
2000-06-28 | 2726.42 | 未披露 | 定期报告 | 2000-06-20 |
2000-06-28 | 2283.23 | 未披露 |
更多>>
from MARCH 31, 1999 to MARCH 31,2000
For cash
Pursuant to exercise of stock options
Pursuant to exercise of Agent's Special Warrants
Issued for corporate finance services
Issued pursuant to exercise of Special Warrants
Cancelled escrow shares
|
2000-03-31 |
1999-06-29 | 2166.63 | 未披露 |
更多>>
from MARCH 31, 1998 to MARCH 31, 1999
For cash
Pursuant to private placement
Pursuant to exercise of stock options
Pursuant to exercise of warrants
|
1999-03-31 |
INOVIO announced that a 1-for-12 reverse stock split of its outstanding shares of common stock will be effective as of 5:00 p.m. Eastern Time on Wednesday, January 24, 2024.
From June 30, 2023 to September 30, 2023
Issuance of common stock for cash, net of financing costs
Vesting of RSUs, net of tax payments
From December 31, 2022 to March 31, 2023
Issuance of common stock for legal settlement
Vesting of RSUs, net of tax payments
From December 31, 2021 to December 31, 2022
Exercise of stock options for cash and vesting of RSUs, net of tax payments
Issuance of common stock for cash, net of financing costs
From June 30, 2022 to September 30, 2022
Issuance of common stock for cash, net of financing costs
Exercise of stock options for cash and vesting of RSUs, net of tax payments
From March 31, 2022 to June 30, 2022
Issuance of common stock for cash, net of financing costs
Exercise of stock options for cash and vesting of RSUs, net of tax payments
From December 31, 2021 to March 31, 2022
Issuance of common stock for cash, net of financing costs
Exercise of stock options for cash and vesting of RSUs, net of tax payments
From December 31, 2020 to December 31, 2021
Issuance of common stock for cash, net of capital raising related expenses
Conversion of December 2019 Bonds to common stock
Exercise of stock options for cash and vesting of RSUs, net of tax payments
From June 30, 2021 to September 30, 2021
Exercise of stock options for cash and vesting of RSUs, net of tax payments
From March 31, 2021 to June 30, 2021
Exercise of stock options for cash and vesting of RSUs, net of tax payments
From December 31, 2020 To March 31, 2021
Issuance of common stock for cash, net of financing costs of $531,000
Conversion of December 2019 Bonds to common stock
Exercise of stock options for cash and vesting of RSUs, net of tax payments
1.Common stock offered by the company 17,700,000 shares of common stock.
2.The above discussion is based on 186,392,777 shares of common stock outstanding, which represents 167,528,435 shares of common stock outstanding as of September 30, 2020.
from December 31, 2019 to December 31, 2020
Conversion of preferred stock to common stock
Issuance of common stock for cash
Conversion of senior notes to common stock
Conversion of August 2019 Bonds to common stock
Exercise of stock options for cash and vesting of RSUs, net of tax payments
From June 30, 2020 to September 30, 2020
Conversion of senior notes to common stock
Conversion of August 2019 Bonds to common stock
Exercise of stock options for cash and vesting of RSUs,net of tax payments
From March 31, 2020 to June 30, 2020
Conversion of preferred stock to common stock
Exercise of stock options for cash and vesting of RSUs, net of tax payments
Issuance of common stock for cash
From December 31, 2019 to March 31, 2020
Issuance of common stock for cash
Exercise of stock options for cash and vesting of RSUs, net of tax payments
from December 31, 2018 to December 31, 2019
Issuance of common stock for cash
Exercise of stock options for cash and vesting of RSUs, net of tax payments
from June 30, 2019 to September 30, 2019
Issuance of common stock for cash
Vesting of RSUs
from March 31, 2019 to June 30,2019
Exercise of stock options and warrants for cash and vesting of RSUs, net of tax payments
from December 31, 2018 to March 31, 2019
Issuance of common stock for cash
Exercise of stock options and warrants for cash and vesting of RSUs, net of tax payments
from December 31, 2017 to December 31, 2018
Issuance of common stock for cash
Exercise of stock options and warrants for cash and vesting of RSUs, net of tax payments
from December 31, 2016 to December 31, 2017
Issuance of common stock for cash, net of financing costs of $4.9 million
Exercise of stock options for cash and vesting of RSUs, net of tax payments
From December 31, 2015 to December 31, 2016
Issuance of common stock for cash, net of financing costs of $128,000
Issuance of common stock for Bioject acquisition
Exercise of stock options and warrants for cash, net of tax payments
Cashless exercise of stock options and warrants
from December 31, 2014 to December 31, 2015
Issuance of common stock for cash, net of financing costs of $4.0 million
Exercise of stock options and warrants for cash
from December 31, 2013 to December 31, 2014
Issuance of shares related to reverse stock split
Issuance of common stock for cash, net of financing costs of $4.0 million
Conversions of preferred stock to common stock
Exercise of stock options and warrants for cash
Cashless exercise of warrants
On June 5, 2014, we effectuated a 4-for-1 reverse split of the Company's outstanding common stock
from December 31, 2012 to December 31, 2013
Issuance of common stock and warrants for cash, net of financing costs of $783,000
Issuance of common stock for cash, net of financing costs of $585,000
Exercise of stock options and warrants for cash
Cashless exercise of warrants
from December 31, 2011 to December 31, 2012
Issuance of common stock for cash, net of financing costs of $164,695
from December 31, 2010 to December 31, 2011
Issuance of common stock for cash, net of financing costs of $41,838
Issuance of common stock and warrants for cash, net of financing costs of $1.3 million
Issuance of common stock and warrants for cash, net of financing costs of $314,871
Exercise of stock options and warrants for cash
from December 31, 2009 to December 31, 2010
Issuance of common stock for cash, net of financing costs of $71,839
Exercise of stock options for cash
from December 31,2008 to December 31,2009
Issuance of common stock to VGX Pharmaceutical Shareholders
Issuance of common stock and warrants for cash, net of financing costs of $1.6 million
Exercise of stock options for cash
Cashless exercise of stock options
Conversions of preferred stock to common stock
Conversion of convertible debt to common stock
Stock-based compensation
from December 31,2007 to December 31,2008
Exercise of stock options for cash
Conversions of preferred stock to common stock
Issuance of common stock for consulting services
Stock-based compensation
from December 31,2006 to December 31,2007
Exercise of warrants for cash
Exercise of stock options for cash
Cashless exercise of warrants
Conversions of preferred stock to common stock
Conversions of ordinary shares to common stock
Issuance of common stock for consulting services
Issuance of common stock for cash, net of issuance costs of $110,313
Share-based compensation
from December 31,2005 to December 31,2006
Conversions of preferred stock to common stock
Exercise of stock options for cash
Issuance of common stock for patents and other assets
Issuance of common stock for cash, net of issuance costs of $1,161,070
Issuance of common stock for consulting service
Share-based compensation
Imputed and declared dividends
from December 31,2004 to December 31,2005
Exercise of stock options for cash
Exercise of warrants for cash
Cashless exercise of warrants
Issuance of common stock for cash, net of issuance costs of $997,682
Issuance of Series D preferred stock for acquisition of Inovio AS
Conversions of preferred stock to common stock
Imputed and declared dividends
Upon conversion, the Series C Preferred Stock outstanding as of December 31, 2005 would convert into 495,769 shares of our common stock.
Upon conversion, the Series A and B Preferred Stock would convert into a total of 573,808 shares of our common stock.
from December 31,2003 to December 31,2004
Exercise of stock options for cash
Exercise of warrants for cash
Cashless exercise of warrants
Conversions of preferred stock to common stock
Declared dividends
Issuance of Series C preferred stock for cash, net of issuance costs of$1,170,363
Reversal of declared dividends
Effective September 13, 2004, we implemented a one-for-four reverse split of our common stock.
from December 31,2002 to December 31,2003
Issuance of preferred stock net of issuance cost of $1,058,864 for cash
Issuance of common stock for corporate finance services
Exercise of stock options for cash
Exercise of warrants for cash
Conversions of preferred stock to common
Declared dividends
from December 31,2001 to December 31,2002
Exercise of stock options for cash
Exercise of warrants for cash
Issued pursuant to exercise of special warrants (net of issuance costs of $413,833 incurred in 2002)
Issued pursuant to exercise of series A special warrants
Issued pursuant to exercise of special warrants
Common stock issued pursuant to services
In October 2002, these special warrants were converted into 10,225,891 shares of common stock and 3,557,976 common stock purchaser warrants.
from MARCH 31,2001 to December 31,2001
Exercise of stock options for cash
from MARCH 31,2000 to MARCH 31,2001
For cash
Pursuant to private placement
Pursuant to exercise of stock options
Pursuant to exercise of warrants
Issued for corporate finance services
Issued pursuant to exercise of Special Warrants
Issued pursuant to license agreement
from MARCH 31, 1999 to MARCH 31,2000
For cash
Pursuant to exercise of stock options
Pursuant to exercise of Agent's Special Warrants
Issued for corporate finance services
Issued pursuant to exercise of Special Warrants
Cancelled escrow shares
from MARCH 31, 1998 to MARCH 31, 1999
For cash
Pursuant to private placement
Pursuant to exercise of stock options
Pursuant to exercise of warrants